At the news
? BEARISHIMPACT 5/10 144 filed Nov 2, 2026 at 12:25 ET
CEO Erez Israeli filed a Form 144 notice of intent to sell 460,726 ADRs of Dr. Reddy's Laboratories, valued at approximately $834.6 million based on the filing's reference price. This represents a substantial portion of the CEO's holdings and is a significant insider sale signal.
- CEO Erez Israeli filed Form 144 to sell 460,726 ADRs
- Approximate market value of proposed sale: $834.6 million
- Shares acquired via stock options exercised on 10/28/2026
- Filing date: 2026-11-02; proposed sale date: 10/29/2026 (already past at filing)
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access